May 2, 2019
Axial Biotherapeutics develops AB-2004 as potential treatment for gastrointestinal dysfunction
– Preclinical results support development of AB-2004 as potential treatment for gastrointestinal dysfunction and associated behavioral symptoms of Autism Spectrum…